SIMILAC TOTAL COMFORT 1

Similac® Total Comfort 1 (0-12 months) 820g

LEADING THROUGH HMO INNOVATION FOR A BROAD SPECTRUM OF INTOLERANCE ISSUES

  • Suitable for infants (0-12 months) who have GI intolerance issues1,2
  • Clinically proven for a fast relief of GI intolerance symptoms in 1 day and sustained the improvement over 28 days1
  • 4X specialized formula: 100% pHF whey protein, 98% lactose free, no palm olein oil, fortified with prebiotics (FOS) formula manages lactose intolerance and GI intolerance issues1,3,4, and may help reduce the risk of cow mik protein allergy in high-risk babies; pHF and dual immune blend HMO** & NTsØ are designed for reducing allergenicity5^ and optimizing immune response6,7
  • Unique dual carbohydrate blend is designed for better digestion and absorption8

 

IMPORTED FROM SPAIN

Ingredients

Maltodextrin, VEGETABLE OILS (high oleic sunflower oil, soy oil, coconut oil), partially hydrolyzed whey protein, sucrose, MINERALS (potassium phosphate, tricalcium phosphate, calcium citrate, potassium chloride, sodium chloride, magnesium chloride, acidity regulator (potassium hydroxide), sodium citrate, calcium hydroxide, ferrous sulfate, zinc sulfate, potassium citrate, copper sulfate, manganese sulfate, potassium iodide, sodium selenite), fructo-oligosaccharides (FOS), arachidonic acid (AA), choline chloride, VITAMINS (ascorbic acid, antioxidant (ascorbyl palmitate), RRR-alpha tocopheryl acetate, sodium ascorbate, niacinamide, calcium d-pantothenate, riboflavin, Vitamin A palmitate, thiamin hydrochloride, pyridoxine hydrochloride, folic acid, phylloquinone, d-biotin, cholecalciferol, cyanocobalamin), 2'-fucosyllactose (2'-FL)(oligosaccharide), docosahexaenoic acid (DHA), L-phenylalanine, NUCLEOTIDES (cytidine 5'-monophosphate, disodium uridine 5'-monophosphate, disodium guanosine 5'-monophosphate, adenosine 5'-monophosphate), L-histidine, taurine, myo-inositol, acidity regulator (citric acid), L-carnitine, antioxidant (mixed tocopherols), CAROTENOIDS (lutein, beta carotene)

Contains milk and soy ingredients. Source of protein - cow's milk protein.

Nutrition Information

Nutrition Information
UnitPer 100gPer 100ml
 
UnitPer 100gPer 100ml
Energykcal51168Niacinmg3.990.53
Proteing11.741.56Vitamin B6μg31642
Total Fatg27.543.66Folic acidµg608
  Linoleic acidsg4.290.57Vitamin B12μg1.810.24
  α-Linolenic acidmg42156Biotinμg18.12.4
 Arachidonic acid (AA)mg10514Pantothenic acidmg3.010.40
  Docosahexaenoic acid (DHA)mg537Sodiummg23331
Total Carbohydratesg54.717.27Potassiummg58778
  Fructo-oligosaccharides (FOS)g1.350.18Chloridemg32443
  2'-fucosyllactose (2'-FL)(oligosaccharide)g0.150.02Calciummg42957
Carnitinemg7.51.0Phosphorusmg30941
Taurinemg27.13.6Magnesiummg30.94.1
Cholinemg127.216.9Ironmg5.040.67
Inositolmg21.12.8Zincmg3.310.44
Nucleotidesmg43.65.8Copperµg30941
Vitamin Aµg RE39553Manganeseµg7510
Vitamin D3µg6.400.85Seleniumµg14.31.9
Vitamin Emg α-TE10.61.4Iodineμg79.010.5
Vitamin Kµg39.95.3Luteinμg689
Vitamin Cmg81.310.8Beta-caroteneμg456
Thiamine (Vitamin B1)µg41455    
Riboflavin (Vitamin B2)µg60280    

RELATED PRODUCTS

RELATED CONTENT

Examining guidelines and new evidence in oncology nutrition

Examining guidelines and new evidence in oncology nutrition

Main Image


resource

Tagname
Article
title
Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/Examining-guidelines-and-new-evidence-in-oncology-nutrition-a-position-paper-on-gaps-and-opportunities-in-multimodal-approaches-to-improve-pati
Abstract

Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognised and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes. 

Publish Date:
Oct 2021

The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)

Main Image

resource

Tagname
ARTICLE
title
The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/hmb-article
Abstract

The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 read this short article to learn more about the benefits of HMB.

Publish Date:

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

Main Image

resource

Tagname
Article
title
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/The-Underappreciated-Role-of-Low-Muscle-Mass-in-the-Management-of-Malnutrition
Abstract

This opinion article, published in Journal of American Medical Directors Association (JAMDA), addresses the role of muscle mass in improving health outcomes in a variety of disease states. It also offers strategies you can use to help patients manage low muscle mass and prevent muscle loss.

Publish Date:
Jan 2019

Footnotes:

**HMO: Human Milk Oligosaccharide (2'-FL [2’ Fucosyllactose]; 20mg/100ml), not from human milk. 

øNTs: Nucleotides (Stage 1: 5.8mg/100ml; Stage 2: 2.1mg/100ml). 

^Partially hydrolyzed whey protein formulas have been shown to reduce the incidence of eczema during the first 3 years in infants at risk of allergy. 

References:

  1. Reverri EJ, et al. Nutrients. 2018;10(10):1346. 
  2. Nevo N, et al. J Pediatr Gastroenterol Nutr. 2007;45(2):234-239. 
  3. Kanabar D, et al. J Hum Nutr Diet. 2001;14(5):359-363. 
  4. Infante D, et al. World J Gastroenterol. 2011;17(16):2104-2108. 
  5. von Berg A, et al. J Allergy Clin Immunol. 2008;121(6):1442-1447. 
  6. Goehring KC, et al. J Nutr. 2016;146(12):2559-2566. 
  7. Buck RH, et al. Pediatr Res. 2004;56(6):891-900. 
  8. Southgate DA. Am J Clin Nutr. 1995;62(1 Suppl):203S-211S.

 

HKG.2025.58161.PND

Order ID: #12345
Order Date: 01/05/2024
Product Product Flavour Product Quantity
Loading...

SESSION TIMEOUT

Your session is about to expire in {min} minutes and you will be logged out. Do you wish to stay logged in?
UK-N/A-2400058 (V8) | October 2024

You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.

You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.

UK-N/A-2400058 (V8) | October 2024
bookmarkbookmarkedbookmark-hover
Click here to add this page to your bookmarks.

This page has been added to your bookmark. To access your bookmark list, Click this link.